Continued Overall Survival Benefit After 5 Years' Follow-up with Bortezomib-Melphalan-Prednisone (VMP) Versus Melphalan-Prednisone (MP) in Patients with Previously Untreated Multiple Myeloma, and No Increased Risk of Second Primary Malignancies: Final Results of the Phase 3 VISTA Trial

被引：0

作者：

San Miguel, Jesus F. ^{[1
]}

Schlag, Rudolf ^{[2
]}

Khuageva, Nuriet K. ^{[3
]}

Dimopoulos, Meletios Athanasios ^{[4
]}

Shpilberg, Ofer ^{[5
]}

Kropff, Martin ^{[6
]}

Spicka, Ivan ^{[7
]}

Petrucci, Maria T. ^{[8
]}

Palumbo, Antonio ^{[9
]}

Samoilova, Olga S. ^{[10
]}

Dmoszynska, Anna ^{[11
]}

Abdulkadyrov, Kudrat M. ^{[12
]}

Delforge, Michel ^{[13
]}

Jiang, Bin ^{[14
]}

Mateos, Maria-Victoria ^{[1
]}

Anderson, Kenneth C.

Esseltine, Dixie-Lee ^{[16
]}

Liu, Kevin ^{[17
]}

Deraedt, William M. ^{[18
]}

Cakana, Andrew Z. ^{[19
]}

van de Velde, Helgi ^{[18
]}

Richardson, Paul G. ^{[15
]}

机构：

[1] Hosp Clin Univ, Salamanca, Spain

[2] Praxisklin Dr Schlag, Wurzburg, Germany

[3] SP Botkin Moscow City Clin Hosp, Moscow, Russia

[4] Univ Athens, Sch Med, Dept Clin Therapeut, GR-11527 Athens, Greece

[5] Rabin Med Ctr, Inst Hematol, Petah Tiqwa, Israel

[6] Univ Munster, Munster, Germany

[7] Charles Univ Prague, Prague, Czech Republic

[8] Univ Roma La Sapienza, Rome, Italy

[9] Univ Turin, Div Hematol, Myeloma Unit, AOU S Giovanni Battista, Turin, Italy

[10] Nizhnii Novgorod Reg Clin Hosp, Novgorod, Russia

[11] Med Univ Lublin, Lublin, Poland

[12] St Petersburg Clin Res Inst Hematol & Transfusiol, St Petersburg, Russia

[13] Belgian Hematol Soc, Myeloma Study Grp, Brussels, Belgium

[14] Peking Univ, Peoples Hosp, Inst Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing 100871, Peoples R China

[15] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[16] Millennium Pharmaceut Inc, Cambridge, MA USA

[17] Janssen Res & Dev, Raritan, NJ USA

[18] Janssen Res & Dev, Beerse, Belgium

[19] Janssen Res & Dev, High Wycombe, Bucks, England

来源：

BLOOD | 2011年 / 118卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：221 / 222

页数：2

共 11 条

[11] Outcomes with two different schedules of bortezomib, melphalan, and prednisone (VMP) for previously untreated multiple myeloma: matched pair analysis using long-term follow-up data from the phase 3 VISTA and PETHEMA/GEM05 trials
Mateos, Maria-Victoria
Oriol, Albert
Martinez-Lopez, Joaquin
Teruel, Ana-Isabel
Bengoechea, Enrique
Palomera, Luis
de Arriba, Felipe
Esseltine, Dixie-Lee
Cakana, Andrew
Pei, Lixia
van de Velde, Helgi
San Miguel, Jesus
ANNALS OF HEMATOLOGY, 2016, 95 (12) : 2033 - 2041

← 1 2 →